Načítá se...
Premedication with pioglitazone prevents doxorubicin-induced left ventricular dysfunction in mice
BACKGROUND: Doxorubicin (DOX) is widely used as an effective chemotherapeutic agent for cancers; however, DOX induces cardiac toxicity, called DOX-induced cardiomyopathy. Although DOX-induced cardiomyopathy is known to be associated with a high cumulative dose of DOX, the mechanisms of its long-term...
Uloženo v:
| Vydáno v: | BMC Pharmacol Toxicol |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8103594/ https://ncbi.nlm.nih.gov/pubmed/33962676 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40360-021-00495-w |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|